Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2003-8-5
pubmed:abstractText
The syntrophins and dystrobrevins are members of the dystrophin-associated protein complex, and are thought to function as modular adaptors for signalling proteins recruited to the sarcolemmal membrane. We have characterised the expression of the syntrophins (alpha-, beta1-, and beta2-) and alpha-dystrobrevin by immunohistochemistry in normal human muscle and in biopsies from 162 patients with myopathies of unknown aetiology (with normal staining for dystrophin and other dystrophin-associated proteins). Unlike mice, beta2-syntrophin is expressed at the sarcolemma in post-natal human skeletal muscle. Deficiency of alpha-dystrobrevin +/- beta2-syntrophin was present in 16/162 (10%) patients, compared to age-matched controls. All patients presented with congenital-onset hypotonia and weakness, although there was variability in clinical severity. Two major clinical patterns emerged: patients with deficiency of beta2-syntrophin and alpha-dystrobrevin presented with severe congenital weakness and died in the first year of life, and two patients with deficiency of alpha-dystrobrevin had congenital muscular dystrophy with complete external ophthalmoplegia. We have sequenced the coding regions of alpha-dystrobrevin and beta2-syntrophin in these patients, and identified a new isoform of dystrobrevin, but have not identified any mutations. This suggests that disease causing mutations occur outside the coding region of these genes, in gene(s) encoding other components of the syntrophin-dystrobrevin subcomplex, or in gene(s) responsible for their post-translational modification and normal localisation.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0960-8966
pubmed:author
pubmed:issnType
Print
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
456-67
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:12899872-Adult, pubmed-meshheading:12899872-Alternative Splicing, pubmed-meshheading:12899872-Blotting, Western, pubmed-meshheading:12899872-Child, Preschool, pubmed-meshheading:12899872-Cytoskeletal Proteins, pubmed-meshheading:12899872-DNA, Complementary, pubmed-meshheading:12899872-DNA Mutational Analysis, pubmed-meshheading:12899872-Dystrophin-Associated Proteins, pubmed-meshheading:12899872-Female, pubmed-meshheading:12899872-Humans, pubmed-meshheading:12899872-Immunohistochemistry, pubmed-meshheading:12899872-Infant, pubmed-meshheading:12899872-Infant, Newborn, pubmed-meshheading:12899872-Male, pubmed-meshheading:12899872-Membrane Proteins, pubmed-meshheading:12899872-Muscle, Skeletal, pubmed-meshheading:12899872-Muscular Dystrophies, pubmed-meshheading:12899872-Prospective Studies, pubmed-meshheading:12899872-Retrospective Studies
pubmed:year
2003
pubmed:articleTitle
Deficiency of the syntrophins and alpha-dystrobrevin in patients with inherited myopathy.
pubmed:affiliation
Institute for Neuromuscular Research, The Children's Hospital at Westmead, Locked Bag 4001, NSW 2145, Westmead, Australia.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't